Literature DB >> 7809048

Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein.

M G Frattini1, L A Laimins.   

Abstract

The papillomavirus E1 and E2 proteins form heteromeric complexes and individually bind specific sequences within the viral origin of replication. The mechanism by which these proteins are recruited to the origin and the role of the E1/E2 complex in replication remain undefined. To examine the interplay of these replication proteins, we have analyzed the binding of human papillomavirus (HPV) type 31b E1 and E2 proteins to the origin of replication. Binding of E1 to the origin was increased by E2 proteins and required the presence of E2 binding sites. This increase was due to the formation of E1/E2 complexes which preferentially bound E2-responsive sequences, and the magnitude was determined by the relative affinity of the E2 binding sites. While the E1 protein alone bound an A/T-rich sequence at the HPV-31b origin with low affinity, complexes of E1 and E2 bound instead to E2 binding sites with high affinity. The E1/E2 complex bound a similar sequence as E2 homodimers, but only E2 homodimer binding induced a significant increase in hypersensitivity as indicated by DNase I footprinting. In the presence of excess E1, E1 proteins bound both the A/T-rich sequence and E2 binding sites through complex formation with E2. In E2 excess, E1/E2 complexes preferentially formed, and binding was specific for E2 sites. Therefore, changes in the relative amounts of E1 and E2 proteins can dramatically alter the pattern of binding of viral replication factors to the origin. These observations suggest a model whereby modulation of the relative levels of E1 and E2 during the viral life cycle may alter the pattern of origin binding and possibly episomal copy number.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809048      PMCID: PMC45445          DOI: 10.1073/pnas.91.26.12398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro.

Authors:  I L Blitz; L A Laimins
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

2.  Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator.

Authors:  I J Mohr; R Clark; S Sun; E J Androphy; P MacPherson; M R Botchan
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

3.  Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells.

Authors:  P F Lambert; N L Hubbert; P M Howley; J T Schiller
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.

Authors:  D A Wysokenski; J L Yates
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome.

Authors:  R Li; J Knight; G Bream; A Stenlund; M Botchan
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

Review 6.  Transcriptional elements as components of eukaryotic origins of DNA replication.

Authors:  M L DePamphilis
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

7.  Binding of a simian virus 40 T antigen-related protein to DNA.

Authors:  R D McKay
Journal:  J Mol Biol       Date:  1981-01-25       Impact factor: 5.469

8.  Identification of a 68-kilodalton nuclear ATP-binding phosphoprotein encoded by bovine papillomavirus type 1.

Authors:  S Sun; L Thorner; M Lentz; P MacPherson; M Botchan
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

9.  The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b.

Authors:  M G Frattini; L A Laimins
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

10.  Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames.

Authors:  M Ustav; A Stenlund
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

View more
  58 in total

1.  Inhibition of DNA replication of human papillomavirus by using zinc finger-single-chain FokI dimer hybrid.

Authors:  Takashi Mino; Tomoaki Mori; Yasuhiro Aoyama; Takashi Sera
Journal:  Mol Biotechnol       Date:  2014-08       Impact factor: 2.695

2.  The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element.

Authors:  M J O'Connor; W Stünkel; C H Koh; H Zimmermann; H U Bernard
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide.

Authors:  Michaël Lehoux; Amélie Fradet-Turcotte; Mathieu Lussier-Price; James G Omichinski; Jacques Archambault
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Differential effects of the splice acceptor at nucleotide 3295 of human papillomavirus type 31 on stable and transient viral replication.

Authors:  D J Klumpp; F Stubenrauch; L A Laimins
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31.

Authors:  Regina Wilson; Frauke Fehrmann; Laimonis A Laimins
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 6.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 7.  The viral etiology of AIDS-associated malignancies.

Authors:  Peter C Angeletti; Luwen Zhang; Charles Wood
Journal:  Adv Pharmacol       Date:  2008

Review 8.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

9.  Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.

Authors:  Yijan E Chang; Loren Pena; Ganes C Sen; Jung K Park; Laimonis A Laimins
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification.

Authors:  M A Ozbun; C Meyers
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.